Pulmonary Gas Exchange Abnormalities in Patients With Mild COPD
1 other identifier
observational
22
1 country
1
Brief Summary
People with mild chronic obstructive pulmonary disease (COPD) can have significant physiological abnormalities and breathing inefficiency which become more pronounced during the stress of exercise, leading to intolerable breathing discomfort (dyspnea). To better understand the mechanisms of respiratory symptoms and exercise limitation in mild COPD, we will examine detailed lung function tests and other important measurements during rest and exercise in people with mild COPD compared with healthy non-smokers. This will be the first study to uncover the fundamental causes of breathing inefficiency and the related shortness of breath during physical exertion in patients with mild COPD. We hope to demonstrate that one simple measurement during exercise \[the relation (ratio) between the total amount of air breathed (ventilation) and the amount of carbon dioxide breathed out\] gives meaningful information about the extent of damage to the small airways and blood vessels in mild COPD and the overall gas exchanging function of the lungs, without the need for an arterial blood sample. This is a case-controlled observational study not involving an intervention. Participants will complete 2 visits approximately 1 week apart, each conducted at the same time of day. Visit 1 will consiste of screening for iligibility, symptom and activity assessments, pulmonary function tests and an incremental cycle cardiopulmonary exercise test (CPET) for familiarization purposes. Visit 2 will include spirometry followed by an incremental cycle CPET with detailed measures of ventilatory, gas exchange, sensory-perceptual and arterial blood gas responses.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jul 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2015
CompletedFirst Submitted
Initial submission to the registry
January 7, 2015
CompletedFirst Posted
Study publicly available on registry
January 27, 2015
CompletedNovember 20, 2015
November 1, 2015
1.5 years
January 7, 2015
November 19, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
ventilatory equivalent for carbon dioxide (VE/VCO2)
Exercise will consist of a symptom-limited incremental test on a cycle ergometer
Measured at its nadir during an exercise test. Participants will be followed for the amount of time taken to complete 2 study visits, an expected average duration between 1 and 2 weeks.
Secondary Outcomes (3)
dead space to tidal volume ratio (VD/VT)
Measured at standardized work rates during exercise
arterial blood gas measurements
Measured at standardized work rates during exercise
dyspnea intensity measured using the modified 10-point Borg scale
Measured at standardized work rates during exercise
Study Arms (2)
Mild COPD
Symptomatic smokers with mild COPD
Healthy Control
Non-smokers, matched to mild COPD group for age (at least 50 years) and gender
Eligibility Criteria
Patients fitting GOLD grade 1B criteria for mild COPD
You may qualify if:
- Stable symptomatic patients with GOLD grade 1B mild COPD;
- at least 50 years of age;
- a cigarette smoking history ≥20 pack-years;
- a Baseline Dyspnea Index focal score ≤9;
- post-bronchodilator forced expiratory volume in 1 second (FEV1) ≥80 %predicted and an FEV1/forced vital capacity (FVC) ratio \<0.7 and \< lower limit of normal.
You may not qualify if:
- clinically significant comorbidities;
- contraindications to exercise testing;
- history/clinical evidence of asthma;
- body mass index \<18.5 or \>30 kg/m2;
- use of supplemental oxygen.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Queen's Universitylead
- Ontario Lung Associationcollaborator
Study Sites (1)
Respiratory Investigation Unit at Kingston General Hospital
Kingston, Ontario, K7L 2V7, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Denis E O'Donnell, MD, FRCPC
Queen's University and Kingston General Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 7, 2015
First Posted
January 27, 2015
Study Start
July 1, 2013
Primary Completion
January 1, 2015
Study Completion
January 1, 2015
Last Updated
November 20, 2015
Record last verified: 2015-11